ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 315

$555K Total Retail Price of All Prescriptions

Rank: 56 out of 315

422 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 7,331 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LOVASTATIN 611 480 1 8
LOSARTAN POTASSIUM 433 403 2 4
LISINOPRIL 429 359 3 3
METFORMIN HCL 386 330 4 7
ATORVASTATIN CALCIUM 378 351 5 5
FELODIPINE ER 319 275 6 23
AMLODIPINE BESYLATE 282 257 7 2
LEVOTHYROXINE SODIUM 249 243 8 6
ATENOLOL 199 149 9 11
SIMVASTATIN 196 172 10 1
OMEPRAZOLE 173 145 11 9
METOPROLOL SUCCINATE 134 111 12 13
ALENDRONATE SODIUM 124 122 13 12
HYDRALAZINE HCL 111 91 14 98
LIPITOR 111 110 14 44
PRAVASTATIN SODIUM 100 98 16 10
AZITHROMYCIN 93 78 17 39
PREDNISONE 90 55 18 41
PRANDIN 85 74 19 227
HYDROCHLOROTHIAZIDE 85 73 19 16
METOPROLOL TARTRATE 79 62 21 18
ZOLPIDEM TARTRATE 79 49 21 29
CLOPIDOGREL 79 75 21 25
ESCITALOPRAM OXALATE 76 73 24 108
DIOVAN 72 72 25 27
JANUVIA 71 62 26 31
FENOFIBRATE 71 61 26 43
GABAPENTIN 70 39 28 37
GEMFIBROZIL 69 43 29 70
OXYCODONE HCL 67 35 S2 30 57
DONEPEZIL HCL 66 66 31 28
IRBESARTAN 63 63 32 66
ACTONEL 59 51 33 47
BYSTOLIC 59 47 33 73
CIPROFLOXACIN HCL 59 54 33 58
CARVEDILOL 57 39 36 22
ZETIA 55 55 37 84
TAMSULOSIN HCL 54 54 38 21
ACARBOSE 54 42 38 202
PLAVIX 53 40 40 40
ALLOPURINOL 53 47 40 14
ISOSORBIDE MONONITRATE ER 51 45 42 92
METFORMIN HCL ER 50 49 43 33
PANTOPRAZOLE SODIUM 50 48 43 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.